At the 3rd Edition of the International Neurology Conference (INC 2025), neuropharmacology, a branch of pharmacology that investigates drug effects on the nervous system to develop therapeutic compounds for psychiatric and neurological diseases, will be discussed. Neuropharmacology emerged around five decades ago, initially with only four drugs available for nerve disorders: caffeine, morphine, nitrous oxide, and aspirin. Subsequently, many new drugs emerged in the following years. By understanding how drugs work at the molecular level, we can study brain functioning.
Neurochemistry explores the configuration, composition, and roles of neurochemical compounds with a dual nature that both originates from and influences the nervous system. These chemicals include substances such as serotonin, dopamine, oxytocin, and various other neurotransmitters or modulators. Research in this domain delves significantly into endogenous compounds, particularly neurotransmitters, alongside molecular elements that are non-genetic in nature within the nervous system.